Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reissue Patent
2007-02-27
2007-02-27
Wessendorf, T. D. (Department: 1639)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S317000, C530S321000, C930SDIG722, C930SDIG722
Reissue Patent
active
10642006
ABSTRACT:
delete-start id="DEL-S-00001" date="20070227" ?Kalahidedelete-end id="DEL-S-00001" ?insert-start id="INS-S-00001" date="20070227" ?Kahalalideinsert-end id="INS-S-00001" ?F, of formula I below, may be isolated from a sacoglossan. The compound may be used in the manufacture of pharmaceutical compositions or in the treatment of tumors or viral conditions
REFERENCES:
patent: 2004/0214755 (2004-10-01), Albericio
patent: 2004035613 (2004-04-01), None
Hamann et al, J. Org. Chem. (1996), 61, 6594-6600.
Goetz et al, Tetrahedron, 55 (1999), pp. 7729-7746.
UMI Dissertation Services, “Biologically Active Constituents of Some Marine Invertebrates,” Hamann, Mark Todd, Ph.D., University of Hawaii (1992), published Oct. 1993.
Hamann et al., J. Am. Chem. Soc., 115, pp. 5825-5826, Jul. 1, 1993.
Merch Manual, 11thed., pp. 456-459, 761-763, and 1368-1371; published 1969.
Gravalos Dolores G.
Hamann Mark T.
Scheuer Alice E. D.
Morgan & Finnegan L.L.P.
PharmaMar, S.A.
Sonnenfeld Kenneth H.
Wessendorf T. D.
Willis Michael A.
LandOfFree
Kahalalide F and compositions and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kahalalide F and compositions and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kahalalide F and compositions and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3849047